Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Lanreotide 30mg powder and solvent for injection suspension vial |
Is a |
Lanreotide-containing product |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Lanreotide 30mg powder and solvent for injection suspension vial |
Is a |
Product containing somatostatin (medicinal product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Lanreotide 30mg powder and solvent for injection suspension vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Lanreotide (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Lanreotide 30mg powder and solvent for injection suspension vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Somatostatin (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Lanreotide 30mg powder and solvent for injection suspension vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Synthetic hormone agent |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Lanreotide 30mg powder and solvent for injection suspension vial |
Has manufactured dose form |
Injection (product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Lanreotide 30mg powder and solvent for injection suspension vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Lanreotide acetate (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Lanreotide 30mg powder and solvent for injection suspension vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Somatostatin (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Lanreotide 30mg powder and solvent for injection suspension vial |
Is a |
Product manufactured as parenteral dose form |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|